Farmers National Bank purchased a new position in shares of Colgate-Palmolive (NYSE:CL) during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 22,514 shares of the company’s stock, valued at approximately $1,543,000.

A number of other large investors also recently modified their holdings of the stock. Lynch & Associates IN lifted its stake in shares of Colgate-Palmolive by 0.6% in the 1st quarter. Lynch & Associates IN now owns 28,930 shares of the company’s stock valued at $1,983,000 after acquiring an additional 160 shares during the last quarter. First National Bank of Omaha lifted its stake in shares of Colgate-Palmolive by 1.2% in the 1st quarter. First National Bank of Omaha now owns 13,499 shares of the company’s stock valued at $925,000 after acquiring an additional 160 shares during the last quarter. Private Capital Group LLC lifted its stake in shares of Colgate-Palmolive by 4.6% in the 1st quarter. Private Capital Group LLC now owns 3,801 shares of the company’s stock valued at $261,000 after acquiring an additional 168 shares during the last quarter. HighPoint Advisor Group LLC lifted its stake in shares of Colgate-Palmolive by 2.5% in the 4th quarter. HighPoint Advisor Group LLC now owns 7,799 shares of the company’s stock valued at $520,000 after acquiring an additional 193 shares during the last quarter. Finally, Mitchell Mcleod Pugh & Williams Inc. lifted its stake in shares of Colgate-Palmolive by 2.4% in the 1st quarter. Mitchell Mcleod Pugh & Williams Inc. now owns 8,521 shares of the company’s stock valued at $584,000 after acquiring an additional 196 shares during the last quarter. 75.95% of the stock is currently owned by institutional investors and hedge funds.

Shares of NYSE:CL opened at $71.70 on Tuesday. The firm has a market cap of $61.79 billion, a P/E ratio of 24.14, a P/E/G ratio of 4.72 and a beta of 0.81. The company has a debt-to-equity ratio of 32.25, a current ratio of 1.07 and a quick ratio of 0.74. Colgate-Palmolive has a 12-month low of $57.41 and a 12-month high of $73.10.

Colgate-Palmolive (NYSE:CL) last announced its earnings results on Friday, April 26th. The company reported $0.67 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.66 by $0.01. The business had revenue of $3.88 billion during the quarter, compared to analyst estimates of $3.86 billion. Colgate-Palmolive had a negative return on equity of 3,730.37% and a net margin of 15.08%. Colgate-Palmolive’s revenue for the quarter was down 2.9% compared to the same quarter last year. During the same period last year, the company earned $0.74 EPS. Analysts expect that Colgate-Palmolive will post 2.83 earnings per share for the current fiscal year.

The firm also recently declared a quarterly dividend, which was paid on Wednesday, May 15th. Shareholders of record on Friday, April 19th were issued a dividend of $0.43 per share. This is an increase from Colgate-Palmolive’s previous quarterly dividend of $0.42. This represents a $1.72 dividend on an annualized basis and a yield of 2.40%. The ex-dividend date of this dividend was Wednesday, April 17th. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 57.91%.

In other Colgate-Palmolive news, VP Justin Skala sold 92,643 shares of the stock in a transaction dated Tuesday, May 7th. The stock was sold at an average price of $70.78, for a total transaction of $6,557,271.54. Following the completion of the sale, the vice president now directly owns 163,653 shares in the company, valued at approximately $11,583,359.34. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CEO Ian M. Cook sold 17,750 shares of the stock in a transaction dated Friday, March 29th. The stock was sold at an average price of $67.37, for a total value of $1,195,817.50. Following the sale, the chief executive officer now owns 1,130,793 shares of the company’s stock, valued at $76,181,524.41. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 335,211 shares of company stock valued at $23,724,495. Company insiders own 1.14% of the company’s stock.

A number of research analysts have recently commented on CL shares. Wells Fargo & Co reiterated a “hold” rating and issued a $57.00 price target on shares of Colgate-Palmolive in a research note on Friday, January 25th. Morgan Stanley set a $62.00 price target on Colgate-Palmolive and gave the company a “hold” rating in a research note on Tuesday, January 29th. Macquarie set a $57.00 price target on Colgate-Palmolive and gave the company a “hold” rating in a research note on Tuesday, January 29th. Zacks Investment Research cut Colgate-Palmolive from a “hold” rating to a “strong sell” rating in a research note on Wednesday, January 30th. Finally, Jefferies Financial Group reaffirmed a “hold” rating and set a $61.00 target price on shares of Colgate-Palmolive in a research report on Friday, February 1st. One equities research analyst has rated the stock with a sell rating, thirteen have given a hold rating and five have issued a buy rating to the company. The company currently has a consensus rating of “Hold” and a consensus price target of $69.69.

ILLEGAL ACTIVITY NOTICE: “Farmers National Bank Purchases New Stake in Colgate-Palmolive (CL)” was reported by The Cerbat Gem and is the property of of The Cerbat Gem. If you are accessing this news story on another website, it was illegally stolen and republished in violation of US & international trademark & copyright laws. The legal version of this news story can be accessed at https://www.thecerbatgem.com/2019/05/21/farmers-national-bank-purchases-new-stake-in-colgate-palmolive-cl.html.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. It offers oral care products, including toothpastes, toothbrushes, and mouthwashes, as well as pharmaceutical products for dentists and other oral health professionals; and personal care products, such as liquid hand soaps, bar soaps, shower gels, deodorants and antiperspirants, skin care products, and shampoos and conditioners.

Recommended Story: Hedge Funds – Risk or Reward?

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.